Clinical Trials Logo

Clinical Trial Summary

To explore the relationship of treatment-related changes in electrophysiology and those in metabolomics for identification of the underlying metabolic mechanisms for the electrophysiological effects of methylphenidate in children with ADHD.


Clinical Trial Description

Although the efficacy of methylphenidate in reducing the core symptoms of attentiondeficit/ hyperactivity disorder (ADHD) is well documented in clinical trials, no definite biomarker has been identified to differentiate responders from non-responders to methylphenidate treatment for children with ADHD. In addition, the neural and metabolic mechanisms underlying the therapeutic effects of methylphenidate remain to be elucidated. In this 4-year prospective project, the investigators will explore the effects of 12-week treatment with methylphenidate on the electrophysiology and metabolomics of children with ADHD to identify the biomarkers for predicting the clinical response to methylphenidate. In addition, the investigators will explore the metabolic mechanisms through which methylphenidate treatment may modulate the abnormality in the electrophysiology of children with ADHD. Specific Aims: 1. To examine the differences in electrophysiology and metabolomics between children with ADHD and neurotypical controls. 2. To examine the differences in the change of electrophysiology and metabolomics after 12-week treatment with methylphenidate between responders and non-responders in children with ADHD. 3. To explore the relationship of treatment-related changes in electrophysiology and those in metabolomics for identification of the underlying metabolic mechanisms for the electrophysiological effects of methylphenidate in children with ADHD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06073470
Study type Observational
Source National Taiwan University Hospital
Contact Chi-Yung Shang, MD, PhD
Phone +886-2-23123456
Email cyshang@ntu.edu.tw
Status Recruiting
Phase
Start date January 1, 2024
Completion date December 31, 2027

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04807998 - Risk Factors for Pediatric Emergence Agitation and Analysis of Serum or Urine Metabonomics in Children With Agitation
Recruiting NCT03810768 - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting NCT06094439 - Targeted Metabolomics and Spent Embryo Culture Medium
Not yet recruiting NCT05834426 - Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers
Terminated NCT02948114 - The Effect of Feeding Infant Formula Containing Prebiotics and/or Probiotics N/A
Recruiting NCT05891886 - Supplemental Oxygen in Pulmonary Embolism (SO-PE) Early Phase 1
Completed NCT04042519 - The Research of Metabolomics on COPD
Completed NCT03450746 - Metabolic and Physiological Changes During Minor Orthopaedic Surgery in Otherwise Healthy Patients
Recruiting NCT03742843 - A Multi-omics Study of Adenomyosis
Recruiting NCT03742856 - A Multi-omics Study of Epithelial Ovarian Cancer
Terminated NCT02948192 - The Reproductive Microbiome & Perinatal Health Outcomes
Recruiting NCT05243173 - Biomarkers of Response to Systemic Treatments in FH-deficient RCC
Completed NCT02145572 - Metabolomic Profiling in Adolescents With Obesity and Diabetes
Active, not recruiting NCT04781036 - Foot-skin Microbiome and Metabolomics of Pitted Keratolysis N/A
Completed NCT04137042 - Metabolomics of Intraoperative Saline and Balanced Crystalloid Infusion N/A
Completed NCT03819959 - Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma
Completed NCT01436383 - Oxidative Stress in Hypobaric Hypoxia N/A
Active, not recruiting NCT03137628 - Effect of General Anesthesia and Mechanical Ventilation on Plasma Metabolite in Patient With Colorectal Cancer Resection N/A
Recruiting NCT06102655 - Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics Early Phase 1